News
Bipolar patients’ relatives face increased cardiovascular risk
BARCELONA – Cross-sectional study of recently diagnosed young bipolar disorder patients breaks new ground.
News
Big drinkers face newly appreciated massive health burden
BARCELONA – “The numbers are so shocking that you have to take it seriously.”
News
This year’s top papers on mood disorders
BARCELONA – An international expert names her top picks through the first three-quarters of 2018.
News
Improve cognitive symptoms of depression to boost work productivity
BARCELONA – “We now know that treating depression is about more than just getting the mood better,” Dr. Pratap Chokka said.
News
Brexanolone injection quickly improves postpartum depression
BARCELONA – The effects of a single 60-hour infusion lasted at least 30 days.
News
Lithium/cancer link debunked
BARCELONA – A large Swedish national study found no hint of increased cancer risk in bipolar patients on lithium.
News
Promising novel antidepressant cruising in pipeline
BARCELONA – “This is a compound with a very, very rich pharmacology – so rich that we don’t know exactly which of the pharmacologic effects are...
News
Home telemonitoring for heart failure cuts mortality
MUNICH – Large, national German TIM-HF2 trial also shows fewer hospitalizations than with usual care.
News
PCI bests medical therapy for FFR grey zone stable angina
PARIS – Provocative findings from the unblinded, randomized Scottish trial contradict those of blinded ORBITA trial.
News
A new era arrives in alopecia areata therapy
PARIS – Phase 2 study on oral JAK inhibitors for alopecia areata yields promising data.
News
Dupilumab positive in phase 3 study for treating adolescent atopic dermatitis
PARIS – The study was the first-ever phase 3 trial of a biologic in a pediatric atopic dermatitis population.
News
Topical cyclosporine safely tamed atopic dermatitis in 4-week study
PARIS – Therapeutic benefits seen within first week.
News
Pediatric data on novel axillary hyperhidrosis treatment reported
PARIS – Topical anticholinergic pads show reassuring efficacy and safety in long-term extension study.
News
Rivaroxaban bonus: Early unmasking of occult GI cancers
MUNICH – Secondary analysis of COMPASS trial hits pay dirt.
News
Trifarotene cream for acne meets all endpoints in twin phase 3 trials
PARIS – Selectivity for just one of the three retinoic acid receptors results in less of the classic retinoid side effects.